Healthcare -
Biotechnology - NASDAQ - US
$ 1.6
1.3 %
$ 1.02 B
Market Cap
-7.43
P/E
GERN - STOCK-BASED COMPENSATION
Stock-based Compensation GERN - Geron Corporation
31.3 M
LAST VALUE
97.85%
2 YEAR CAGR
38.80%
5 YEAR CAGR
15.13%
10 YEAR CAGR